We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Illinois Tool Works
ITW
$81.9B
| $10M | 0.07% |
57,335
-3,669
| -6% | -$599K |
|
|
ATVI
202
DELISTED
Activision Blizzard
ATVI
| $9.99M | 0.07% |
131,685
+14,157
| +12% | +$988K |
|
|
WORK
203
DELISTED
Slack Technologies, Inc.
WORK
| $9.98M | 0.07% |
+321,003
| New | +$9.65M |
|
204
Booking.com
BKNG
$145B
| $9.98M | 0.07% |
156,650
-260,025
| -62% | -$15.8M |
|
205
Colgate-Palmolive
CL
$73.6B
| $9.93M | 0.07% |
135,502
-8,667
| -6% | -$616K |
|
206
MGM Resorts International
MGM
$11.8B
| $9.84M | 0.07% |
585,394
-1,525,038
| -72% | -$24.6M |
|
207
Dominion Energy
D
$61.8B
| $9.74M | 0.07% |
119,994
-7,194
| -6% | -$577K |
|
208
Biogen
BIIB
$29.5B
| $9.64M | 0.07% |
36,045
-2,183
| -6% | -$656K |
|
209
Ford
F
$58.5B
| $9.58M | 0.07% |
1,574,991
-41,559
| -3% | -$230K |
|
210
Blackrock
BLK
$165B
| $9.5M | 0.07% |
17,453
-1,099
| -6% | -$555K |
|
211
Southern Company
SO
$109B
| $9.39M | 0.07% |
181,099
-11,405
| -6% | -$634K |
|
212
Illumina
ILMN
$28.7B
| $9.33M | 0.07% |
25,905
-1,655
| -6% | -$533K |
|
213
Stanley Black & Decker
SWK
$14.6B
| $9.3M | 0.07% |
66,717
-4,268
| -6% | -$515K |
|
214
SLB Ltd
SLB
$76.5B
| $9.29M | 0.07% |
505,149
-13,235
| -3% | -$232K |
|
215
HCA Healthcare
HCA
$86.4B
| $9.28M | 0.07% |
95,645
+47,080
| +97% | +$4.89M |
|
|
BNY
216
Bank of New York Mellon
BNY
$107B
| $9.27M | 0.07% |
239,841
-62,737
| -21% | -$2.3M |
|
217
Northern Trust
NTRS
$22.4B
| $9.21M | 0.07% |
116,139
-4,705
| -4% | -$373K |
|
218
iShares Russell 2000 Value ETF
IWN
$14.4B
| $9.15M | 0.06% |
93,905
| – | – |
|
219
General Mills
GIS
$19.5B
| $9.14M | 0.06% |
148,187
-9,482
| -6% | -$572K |
|
220
Verisk Analytics
VRSK
$27.1B
| $9.09M | 0.06% |
53,379
-3,415
| -6% | -$540K |
|
221
Xcel Energy
XEL
$50.4B
| $9.04M | 0.06% |
144,696
-9,119
| -6% | -$575K |
|
222
ASML
ASML
$636B
| $8.84M | 0.06% |
24,025
-3,902
| -14% | -$1.22M |
|
223
SLM Corp
SLM
$4.78B
| $8.79M | 0.06% |
+1,250,237
| New | +$9.34M |
|
|
CTXS
224
DELISTED
Citrix Systems Inc
CTXS
| $8.78M | 0.06% |
59,382
-3,725
| -6% | -$536K |
|
225
eBay
EBAY
$50.3B
| $8.77M | 0.06% |
167,212
-10,700
| -6% | -$452K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.